Dr. Reddy’s Laboratories Limited (the “Company”) has entered into a Security Subscription and Shareholders’ Agreement for consumption and supply of renewable energy, with TEQ Green Power XI Private Limited and O2 Power SG Pte Ltd, for investment in O2 Renewable Energy IX Private Limited (“SPV”).
The arrangement for accessing such renewable power will be done through a partnership with TEQ Green Power XI Private Limited and/or its affiliate with security holding ratio of 26% by the Company and 74% by TEQ Green Power XI Private Limited and/or its affiliate, in the SPV.
The Company has the right to nominate 1(one) Director on the Board of SPV, receive first offer in case of transfer of securities of SPV to any third party, right to restrict capital restructuring, except otherwise defined, etc.
The Company and TEQ Green Power XI Private Limited and/or its affiliate will invest in SPV in the ratio of 26:74.
Tags: Dr. Reddy’s Laboratories, O2 Power SG Pte Ltd, Renewable Energy, TEQ Green Power
Recent Posts
Yara Birkeland Marks Three Years of Pioneering Zero-Emission Maritime Operations
HD Hyundai, Maersk Collaborate on Innovation in Decarbonization and Smart Logistics
First ship to have pioneering sensor installed to measure emissions of particles
Incat Tasmania launches world’s largest battery-electric ship
India to supply 4.12 lakh tonne green hydrogen derivatives to Japan, Singapore
Green hydrogen gets official stamp as India notifies certification scheme
Wärtsilä expands methane slip reduction capabilities by introducing NextDF technology
GS E&C, Amogy, and HD Hyundai Infracore partner with South Korean City Pohang-si